SCHEMBL9707464

SCHEMBL9707464

CCCn1c(=O)[nH]c(=O)c2c1nc(C(C)C)n2Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

nearest known ligand 0.45

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.45
KMT2A Q03164 7/20 0.45
KDM4E B2RXH2 7/20 0.45
ALDH1A1 P00352 7/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
HTT P42858 2/20 0.45
MAPT P10636 2/20 0.44
TPH1 P17752 4/20 0.44
TPH2 Q8IWU9 4/20 0.44
HPGD P15428 2/20 0.42
CXCL8 P10145 1/20 0.41
NOD2 Q9HC29 1/20 0.41
NOD1 Q9Y239 1/20 0.41
HSD17B10 Q99714 2/20 0.41
TSHR P16473 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GAA P10253 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9707643 0.93 MEN1 (0.48) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9708303 0.93 ALDH1A1 (0.44) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9707717 0.91 ALDH1A1 (0.49) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9707557 0.91 ALDH1A1 (0.43) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9708130 0.91 CXCL8 (0.49) MEN1KMT2AKDM4EALDH1A1HTT
SCHEMBL9707484 0.89 KDM4E (0.49) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9707739 0.88 ADORA3 (0.47)
SCHEMBL9708861 0.88 TPH1 (0.51) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9708857 0.88 ALDH1A1 (0.39) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2
SCHEMBL9707811 0.87 TPH1 (0.51) MEN1KMT2AKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1992007852-A1 BIPHENYLALKYL XANTHINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1992-05-14 WO disclosed